Lessons to Europe from China for cancer treatment during the COVID-19 pandemic
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
While cancer patients might have a higher risk of harm compared with patients without cancer if infected with SARS–CoV2,1,2 the degree of elevated risks if any remains uncertain and will be based on numerous host-, tumour- and treatment-related factors. Compared with the European medical system, there are some measures worth learning from China, from our experience working with cancer patients during the pandemic. (...)
British Journal of Cancer , commentaire en libre accès, 2019